CD4 and neoplasm: It has also been reported that progressive tumor growth in syngeneic mice leads to independent sensitization of both TDLN L-selectinlow CD4 and CD8 cells, with CD4 cells being more effective against 3-day established intracranial and pulmonary tumors and CD8 cells more effective against 10-day established tumors [25].